On April 13th, Bafna Pharmaceuticals experienced a significant drop of 5%, closing at Rs 133.87 due to an excessive selling pressure and lack of buying interest, leading to a supply-demand imbalance.

Bafna Pharma experienced a significant drop today, closing at Rs 108.42 - a decline of nearly 5%. The trading session was marked by intense selling pressure and minimal buying interest, indicating an unfavorable supply-demand ratio.